Dr. Bunn Discusses the Potential Benefit for a Blood-Based Test to Detect a T790M Mutation Targeted Oncology 2:51 10 years ago 76 Далее Скачать
Dr. Bunn Discusses Afatinib for Patients with EGFR mutation Targeted Oncology 1:35 11 years ago 228 Далее Скачать
Liquid vs. Tissue Biopsies to Detect T790M Mutations GRACE - Global Resource for Advancing Cancer Education 8:29 8 years ago 347 Далее Скачать
Blood-Based Mutation Testing: Circulating Tumor Cells and Tumor DNA GRACE - Global Resource for Advancing Cancer Education 2:49 8 years ago 531 Далее Скачать
Dr. Lynch Discusses Treating Patients With T790M-Mutant NSCLC Targeted Oncology 0:55 9 years ago 80 Далее Скачать
Dr. Camidge on Inhibiting Initial Activating EGFR Mutations and the T790M Resistance Mutation OncLive 0:58 10 years ago 246 Далее Скачать
Dr. Bunn Discusses Companion Diagnostic Tests in Lung Cancer OncLive 1:36 10 years ago 131 Далее Скачать
John Longshore - Recent Progress in Predictive Biomarker Testing in Oncology Labroots 57:40 8 years ago 358 Далее Скачать
Predicting patient response to BTK inhibitors using novel approaches VJHemOnc – Video Journal of Hematology & HemOnc 1:14 2 years ago 197 Далее Скачать
Could blood tests diagnose #alzheimers #alzheimersawareness #podcastshow Laura Dowling 0:28 1 year ago 176 Далее Скачать
Dr. Bunn on Initial Results of the MYSTIC Trial in Stage IV Lung Cancer OncLive 2:06 7 years ago 137 Далее Скачать
Dr. Bunn on Current Role of Precision Medicine for Lung Cancer OncLive 1:14 8 years ago 114 Далее Скачать
Dr. Bunn on Data With Trastuzumab Deruxtecan in HER2-Mutant NSCLC OncLive 1:10 4 years ago 294 Далее Скачать
Findings from a Phase I/II trial of nuvisertib in the treatment of R/R myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 3:20 2 days ago 81 Далее Скачать
BO-112: Enhancing immune-checkpoint inhibition in solid tumors VJOncology 0:47 2 years ago 74 Далее Скачать
Biomarkers to help predict response to CDK4/6 inhibitors VJOncology 1:04 2 years ago 104 Далее Скачать
